- Home
- ENFN
ENFN
Enfusion Inc.
as 01-17-2025 4:00pm EST
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 1.0B | IPO Year: | 2021 |
| Target Price: | $10.10 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Hold | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.03 | EPS Growth: | -56.68 |
| 52 Week Low/High: | $7.52 - $11.38 | Next Earning Date: | 03-11-2025 |
| Revenue: | $195,159,000 | Revenue Growth: | 15.78% |
| Revenue Growth (this year): | 18.88% | Revenue Growth (next year): | 17.75% |
Stock Insider Trading Activity of Enfusion Inc. (ENFN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Somers Deirdre | ENFN | Director | Jan 13 '25 | Sell | $10.53 | 1,637 | $17,237.61 | 41,675 | |
| Herring Bradley | ENFN | Chief Financial Officer | Jan 7 '25 | Sell | $10.13 | 4,134 | $41,877.42 | 266,369 | |
| Bastone Bronwen | ENFN | Chief People Officer | Jan 7 '25 | Sell | $10.13 | 809 | $8,195.17 | 194,885 | |
| Gutowski Valeria | ENFN | Chief Accounting Officer | Jan 7 '25 | Sell | $10.13 | 796 | $8,063.48 | 34,803 | |
| Campobasso Matthew | ENFN | General Counsel | Jan 7 '25 | Sell | $10.13 | 976 | $9,886.88 | 52,651 | |
| Movchan Oleg | ENFN | Chief Executive Officer | Jan 7 '25 | Sell | $10.13 | 2,771 | $28,070.23 | 526,702 | |
| Herring Bradley | ENFN | Chief Financial Officer | Dec 20 '24 | Sell | $10.61 | 24,443 | $259,340.23 | 266,369 | |
| Pawar Neal | ENFN | Chief Operating Officer | Dec 2 '24 | Sell | $10.06 | 48,047 | $483,486.17 | 1,117,298 | |
| Pawar Neal | ENFN | Chief Operating Officer | Nov 29 '24 | Sell | $9.92 | 19,226 | $190,721.92 | 1,117,298 | |
| Campobasso Matthew | ENFN | General Counsel | Oct 22 '24 | Sell | $8.95 | 674 | $6,032.30 | 52,651 |
Latest Enfusion Inc. News
ENFN Breaking Stock News: Dive into ENFN Ticker-Specific Updates for Smart Investing
Investing.com
4 days ago
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid
Simply Wall St.
4 days ago
Exploring Three High Growth Tech Stocks in the United States
TipRanks
5 days ago
Enfusion downgraded to Hold from Buy at Stifel
Simply Wall St.
5 days ago
3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025
MT Newswires
5 days ago
Morgan Stanley Downgrades Enfusion to Equalweight From Overweight, Lifts Price Target to $11.25 From $11
MT Newswires
5 days ago
Sector Update: Tech
MT Newswires
6 days ago
Clearwater Analytics to Buy Enfusion for $1.5 Billion in Cash, Stock
Reuters
6 days ago
Clearwater to buy software maker Enfusion for $1.5 billion in expansion push
Compare ENFN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENFN Enfusion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.